<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03336801</url>
  </required_header>
  <id_info>
    <org_study_id>ANIMAL-523-2014-2569</org_study_id>
    <nct_id>NCT03336801</nct_id>
  </id_info>
  <brief_title>The Effect of Propofol or Sevoflurane on Renal Function</brief_title>
  <official_title>The Effect of Propofol and Sevoflurane Anesthesia on Renal Function in Patients Undergoing Back Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the role of the anesthetic agents propofol and sevoflurane on renal
      function in otherwise healthy patients undergoing basic back surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Water-sodium homeostasis is central for anyone undergoing surgery, and can therefore affect
      surgical outcome, level of postoperative care and the length of hospital stay. Too much or
      too little fluid during surgery can affect the patients negatively. The kidneys play an
      imperative role in the regulation of water and sodium homeostasis, however there are lack of
      knowledge in how the anesthesia per se affects renal function. Previous studies have shown
      that volatile anesthetic agents such as sevoflurane can cause fluid retention. Why this
      happens is not completely known.

      We are now investigating the different affects of sevoflurane and propofol anesthesia on
      renal function in patients undergoing basic back surgery to elucidate if there is a
      difference in the risk of developing acute kidney injury.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients are randomized into one of two treatment groups which during surgery receives one of two different anesthetic agents. The two groups are then compared to each other.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in urine output</measure>
    <time_frame>24 hours</time_frame>
    <description>Urine output (ml/min) changes during anesthesia, in postoperative care and in the ward unit. Changes will be assessed with AKIN RIFLE and by comparison between the different groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in serum creatinine levels</measure>
    <time_frame>24 hours</time_frame>
    <description>Changes in serum creatinine levels during anesthesia, in postoperative care and in the ward unit. Changes will be assessed with AKIN RIFLE and by comparison between the different groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in creatinine clearance</measure>
    <time_frame>24 hours</time_frame>
    <description>Creatinine clearance changes during anesthesia, in postoperative care and in the ward unit. Changes will be assessed with AKIN RIFLE and by comparison between the different groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in electrolytes</measure>
    <time_frame>24 hours</time_frame>
    <description>Changes in serum and urinary electrolytes (sodium and potassium) will be measured during anesthesia, in postoperative care and in the ward unit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in hormone levels</measure>
    <time_frame>24 hours</time_frame>
    <description>The hormones angiotensin II, anti diuretic hormone and aldosterone will be measured during anesthesia, in postoperative care and in the ward unit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention Back surgery and sevoflurane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention Back surgery and propofol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Back Surgery</intervention_name>
    <description>All patients undergo basic back surgery.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Anesthesia on propofol alone.</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Anesthesia on sevoflurane alone.</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled back surgery

        Exclusion Criteria:

          -  American Association of Anesthesiology class 1-3

          -  American Heart Association class &gt;3

          -  BMI &gt;37

          -  Insulin treated diabetes

          -  Pregnancy or breast feeding

          -  Sensistivity/allergy against anesthetic agents

          -  Inadequate understanding about the study

          -  Depressed kidney function and/or AKI

          -  Depressed liver function

          -  Genetic malignant hyperthermia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Franzén, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University, Department of Anesthesiology and Intensive Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Frithiof, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Uppsala University, Department of Anesthesiology and Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Frithiof, MD PhD</last_name>
    <phone>0736563473</phone>
    <email>robert.frithiof@surgsci.uu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Egidijus Semenas, MD PhD</last_name>
    <email>semenas.egidijus@akademiska.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Akademiska sjukhuset, Centraloperation</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Frithiof, MD PhD</last_name>
      <phone>0736563473</phone>
      <email>robert.frithiof@surgsci.uu.se</email>
    </contact>
    <contact_backup>
      <last_name>Egidijus Semenas, MD PhD</last_name>
      <email>semenas.egidijus@akademiska.se</email>
    </contact_backup>
    <investigator>
      <last_name>Stephanie Franzén, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2017</study_first_submitted>
  <study_first_submitted_qc>November 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2017</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uppsala University</investigator_affiliation>
    <investigator_full_name>Robert Frithiof</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>sevoflurane</keyword>
  <keyword>propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

